Seaport, Hemab launch US IPOs as biotech listings gather momentum
Drug developers Seaport Therapeutics and Hemab Therapeutics launched their U.S. initial public offerings on Monday, seeking to capitalize on a growing investor appetite for new
April 27, 2026
The devil wears Old Navy? Inside Hollywood’s favorite movie marketing blitz
ICC awards $8.4 million in reparations to victims of al-Qaida-linked leader in Mali
Tourist dies after being bitten at snake show while on vacation in Egypt
How electronic warfare is sowing confusion in cockpits
Robot dogs with Musk and Zuckerberg heads roam around Berlin gallery in Beeple's new exhibit
JetBlue's quarterly loss widens as high fuel costs dent margin recovery